() said it has received an additional £450,000 from an open offer that accompanied a £4mln placing two weeks ago.
Acceptances for the offer, which was priced at 16p, amounted to 2.8mln shares said the microbiome specialist.
In total, its means the AIM-listed group has raised £4.45mln, which will be used to expand its product pipeline from skin into haircare, oral and acne.
SkinBioTherapeutics also wants to develop own-label product lines and establish its own in-house scientific capability and related infrastructure.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of SkinBioTherapeutics PLC named herein, including the promotion by the Company of SkinBioTherapeutics PLC in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE